GB0111194D0 - Sequences - Google Patents
SequencesInfo
- Publication number
- GB0111194D0 GB0111194D0 GB0111194A GB0111194A GB0111194D0 GB 0111194 D0 GB0111194 D0 GB 0111194D0 GB 0111194 A GB0111194 A GB 0111194A GB 0111194 A GB0111194 A GB 0111194A GB 0111194 D0 GB0111194 D0 GB 0111194D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27001—Ribonuclease T2 (3.1.27.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0111194A GB0111194D0 (en) | 2001-05-08 | 2001-05-08 | Sequences |
| AU2002311573A AU2002311573A1 (en) | 2001-05-08 | 2002-05-08 | Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer |
| PCT/IB2002/002555 WO2002089829A2 (en) | 2001-05-08 | 2002-05-08 | Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0111194A GB0111194D0 (en) | 2001-05-08 | 2001-05-08 | Sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0111194D0 true GB0111194D0 (en) | 2001-06-27 |
Family
ID=9914200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0111194A Ceased GB0111194D0 (en) | 2001-05-08 | 2001-05-08 | Sequences |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002311573A1 (en) |
| GB (1) | GB0111194D0 (en) |
| WO (1) | WO2002089829A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2600108A1 (en) * | 2004-03-03 | 2005-09-15 | Chaker N. Adra | Granulocyte subtype-selective receptors and ion channels and uses thereof |
| CN113373218A (en) * | 2021-08-04 | 2021-09-10 | 杭州浙大迪迅生物基因工程有限公司 | Primer group and kit for detecting mRNA expression of human eosinophil cationic protein |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0001706D0 (en) * | 2000-05-09 | 2000-05-09 | Astrazeneca Ab | sequences |
-
2001
- 2001-05-08 GB GB0111194A patent/GB0111194D0/en not_active Ceased
-
2002
- 2002-05-08 WO PCT/IB2002/002555 patent/WO2002089829A2/en not_active Ceased
- 2002-05-08 AU AU2002311573A patent/AU2002311573A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002311573A1 (en) | 2002-11-18 |
| WO2002089829A3 (en) | 2003-05-30 |
| WO2002089829A2 (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0108968D0 (en) | Methods | |
| GB0120042D0 (en) | Methods | |
| GB0126251D0 (en) | Methods | |
| GB0111146D0 (en) | Methods | |
| GB0116249D0 (en) | Methods | |
| HU0400176V0 (en) | Improved gasketseal | |
| GB0011459D0 (en) | Sequences | |
| GB0126164D0 (en) | Sequences | |
| GB0008801D0 (en) | Sequences | |
| GB0108534D0 (en) | Retaining means | |
| GB0111194D0 (en) | Sequences | |
| GB0118549D0 (en) | Methods | |
| GB0108110D0 (en) | Keeps | |
| GB0118611D0 (en) | Methods | |
| GB0126163D0 (en) | Sequences | |
| GB0126165D0 (en) | Sequences | |
| GB0125498D0 (en) | Sequences | |
| GB0126397D0 (en) | Sequences | |
| GB2376939B (en) | Retaining means | |
| GB0116076D0 (en) | Methods | |
| IL142390A0 (en) | Metalloprotease sequences | |
| IL141861A0 (en) | Kinase sequences | |
| GB0115225D0 (en) | Nucleotide sequences | |
| GB0126334D0 (en) | Numbers | |
| GB0215980D0 (en) | Sequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application | ||
| AT | Applications terminated before publication under section 16(1) |